Pregnant Woman; Diabeties Complications

Authors

  • Nikita Saraswat Department Pharmacy, Pranveer Singh Institute of Technology, Kanpur - Agra - Delhi National Highway - 2, Bhauti, Kanpur, Uttar Pradesh 209305, India.
  • Pranay Wal Department Pharmacy, Pranveer Singh Institute of Technology, Kanpur - Agra - Delhi National Highway - 2, Bhauti, Kanpur, Uttar Pradesh 209305, India.
  • Neetu Sachan School of Pharmaceutical Sciences, IFTM University, Lodhipur Rajput, Delhi Road (NH-24), Moradabad-244 102 (UP), India.
  • Phool Chandra School of Pharmaceutical Sciences, IFTM University, Lodhipur Rajput, Delhi Road (NH-24), Moradabad-244 102 (UP), India.

Keywords:

Pregnancy, Diabetes, Gestation

Abstract

This paper gives an insight on how important is the management of diabetes for a pregnant women and
diabetic women who are planning to conceive. According to the Society of Obstetricians and Gynaecologists
of Canada (SOGC) it is extremely significant to create awareness about the complications one can face during
pregnancy and child birth. Even trimester shows variable levels of glucose levels whose management is
very much required to maintain a safe pregnancy. It is well known that India has reported huge number of
pregnancies and complications in diabetics (pre-existing type 1 or type 2 diabetes and gestational diabetes
mellitus [GDM]) and the numbers are increasing progressively. The awareness and management has to
be performed under the expert medical professionals with regular guidance by dialectologists has proved
out to be a significant factor in controlling complication to diabetics during the pregnancies.

References

1 Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 2007;30:1920–1925.
2 Jensen DM, Korsholm L, Ovesen P, et al. Periconceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 2009;32:1046– 1048.
3 Charron-Prochownik D, Sereika SM, Becker D, et al. Long-term effects of the boosterenhanced READY-Girls
preconception counseling program on intentions and behaviors for family planning in teens with diabetes.
Diabetes Care 2013;36:3870–3874.
4 Holmes VA, Young IS, Patterson CC, et al.; Diabetes and Pre-eclampsia Intervention Trial Study Group. Optimal glycemic control, preeclampsia, and gestational hypertension in women with type 1 diabetes in the
diabetes and pre-eclampsia intervention trial. Diabetes Care 2011;34:1683–1688.
5 Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes
and obesity: a study of discordant sibships. Diabetes 2000;49:2208–2211.
6 WHO Diabetes Mellitus. World Health Organ TechRep Ser 1985 (729):9-17.
7 National Diabetes Data Group. Classification anddiagnosis of diabetes mellitus and other categoriesof
glucose intolerance. Diabetes 1979;28:1039-1057.
8 Mangan M., Normal fuel metabolism and alterations in diabetes mellitus, Nurse Pract Forum. 1991
Sep;2(3):152-6.
9 Greene MF, Hare JW, Krache M, et al. Prematurityamong insulin-requiring diabetic gravid women. AmJ
ObstetGynecol 1989;161:106-111.
10 Wilson JD, Moore G, Chipps D. Successfulpregnancy in patients with diabetes followingmyocardial infarction. Aust NZ J ObstetGynecol1994;34:604-606.
11 Fog-Pedersen J, Molsted-Pedersen L. Ultrasoundstudies of fetal growth. In: Sutherland H, StowersJ, Pearson
DWN, eds. Carbohydrate metabolism inpregnancy and newborn, IV. Berlin: Springer-Verlag,1989: p. 83-93.
12 Cousins L. Pregnancy complications among diabetic women. Review 1965-1985. ObstetGynaecolSurv
1987;42:140-149.
13 Huff RW. The uses of ultrasound in themanagement of diabetic pregnancies. Diabetic Rev1995;3:647.
14 Caplan RM, et al. Constant intravenous insulininfusion during labour and delivery in diabetesmellitus. Diabetes Care 1982;5:6-10.

Downloads

Published

2018-10-26

How to Cite

Saraswat, N., Wal, P., Sachan, N., & Chandra, P. (2018). Pregnant Woman; Diabeties Complications. Journal of Drug Discovery and Development ( ISSN:2581-6861), 1(1), 37-39. Retrieved from https://medicaljournalshouse.com/index.php/JDrug-Discovery-Development/article/view/52

Issue

Vol. 1 No. 1 (2017): Journal of Drug Discovery and Development

Section

Articles

License

We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-

1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.

2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.

3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.

4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.

5. I/We also agree to the authorship of the article in the following sequence:-

Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________

Important

(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.

(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.

(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.